Digg It - Business

When two companies go head to head, the same principle applies. God smiles on the larger sales for

According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product

ce.

Given a virgin territory, the company with the larger sales force is likely to wind up with t

; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

Examples of combination products may in

he larger share of the market.

Once the market is divided up, the company with the larger share i

lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

s likely to continue to take business away from the smaller company.

The bigger company can affor

here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe

d a bigger advertising budget, a bigger research department, more sales outlets, etc. No wonder th

d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

Combination pro

e rich get richer and the poor get poorer.

Is there no future for the small competitor? Of course

ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc

there is which one reason why this book was written is. (General Motors, General Electric, and IB

easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi

M don’t need to study Clausewitz to be successful.)

But smaller companies with smaller market sha

nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically

res do need to think like field commanders. They must keep in mind the first principle of warfare,

and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ

the principle of force, be it military or marketing. “The art of war with a numerically inferior

ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi

army,” said Napoleon “consists in always having larger forces than the enemy at the point which is

ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

Following aspects would a

to be attacked or defended.”

Custer could have become one of our nation’s most famous heroes if

dd to the challenges in developing combination products:

Which markets to tap where the combination products can do fairly well?
Which combination prod

he could have gotten the Sioux to attack over the hill one at e time.

Military generals know the

cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin

importance of the principle of force. That’s why they spend so much time studying the order of bat

tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen

tle of an opposing force. For purposes of morale, however, a general tries to fire up his troops b

t?

As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel

y telling them what good soldiers they are and what great equipment they have.

“Now we have the f

ping new procedures for reviewing their safety, efficacy and quality.

Professional from academic institutions, pharmaceutical industries, health care indust

inest food, equipment, the best spirit and the best men in the world,” said George C. Scott in his

y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products

role as General George S. Patton, Jr. “You know, by god, I actually pity those poor bastards we’r

.

As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de

e going up against.”

Many marketing generals do the same thing and fall victim to their own rheto

elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

Companies that provide selfless information through particip

ric. In particular they talk themselves into the “better people” or the “better product” fallacies

tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.diggit.org.ua/article/29079/diggit-The-Mathematics-of-a-Marketing-Melee.html">The Mathematics of a Marketing Melee</a>

BB link (for phorums):
[url=http://www.diggit.org.ua/article/29079/diggit-The-Mathematics-of-a-Marketing-Melee.html]The Mathematics of a Marketing Melee[/url]

Maybe one of your customers has mentioned FMEA to you and you are wondering what it is. You would like to find out more about FMEA, but are not sure how. This article has just what you are looking for because it covers all the basics about Failure Mode and Effects Analysis (FMEA).

As consumers, we don't really think about the importance of branding. We just seem to go with the flow of brand names that have become synonymous with our daily living. But the impact of a name reinforces the importance of branding when we promote our business.

Tags

Links

Digg It - The Mathematics of a Marketing Melee

Related Articles: